Enliven Therapeutics, Inc. (ELVN)
ELVNEnliven Therapeutics, Inc.loading…
loading…
QTick signal
0net
2 bull / 2 bear factors · balancedBull 3 pts·Bear 3 pts30d
loading…
Market context—Sector read · not on fileOKBalance sheet · Safe—Inflation-report days · not on fileOKCalm trading · sharp-drop risk 0/100 · Nov 9
Golden cross
50-day average is above the 200-day — an uptrend
Momentum (RSI)67.7fires under 35 · fires below the slider range
Price vs. profitno profit to compare
Last session traded lighter than its own normal. Over the last 20 sessions, 32% of the volume traded on days the stock closed lower.
Entry strategy · 10 triggers
1 of 6 aligned — not yetRSI 14
●
67.7
fires under 35 · fires below the slider range
vs 50-day
●
$47.13
above the line · fires near $47.48
Bollinger
●
$36.03
no lower pierce · fires below the slider range
VWAP 20
●
$42.77
above the rolling VWAP · fires near $42.74
Entry level
✓
$50.69
within 1% of model level
Put wall
●
$45.00
2026-11-20 expiry · chain of 2026-11-10
MACD
Context✓
+0.89
histogram above zero · fading
RVolStatic
0.42×
lighter than its own normal
Short int.Static
17.5%
short interest below 20%
ATRStatic
$2.21
14-session average true range
A checklist, not odds on a return: 4 of 6 usable price conditions have to line up. RSI, the 50-day average and the Bollinger band move with the price you set; the 20-day average traded price, the entry level and the busiest put strike stay fixed. MACD, RVol, Short int. and ATR are context only — they never count toward the total.
Next earnings
2027-03-02
in 75 sessions
Next dividend
No indicated yield
no forward dividend on file